#platformtrials
Yesterday our #EPISeminar continued with the third lecture - Thank you very much, @BenjaminHofner, for a fantastic presentation on #PlatformTrials, innovative designs, the combination research with regulatory considerations and the subsequent discussion.
November 27, 2024 at 8:47 AM
In a survey of platform trial investigators, shared infrastructure was viewed as a key advantage of #PlatformTrials, but planning time, expertise needs, and organizational complexity exceeded those of traditional randomized trials.

ja.ma/41kcJ5M
April 5, 2026 at 6:30 PM
George Picard @leedsctru.bsky.social shares insights from CONCORDE — how platform trial designs are reshaping our monitoring approaches.

#PlatformTrials #UKCRC #UKCTUNetork
June 25, 2025 at 1:19 PM
🧠 BREAKTHROUGH: Platform trials could revolutionize neurological disease research by testing 4x more treatments simultaneously.…

#Alzheimersdisease #Clinicalresearch #Neurologicaldisease #Parkinsonsdisease #Platformtrials

#Alzheimersdisease #Clinicalresearch #Neurologicaldisease #Parkinsonsdise…
Platform Trials Could Revolutionize Brain Disease Research
🧠 BREAKTHROUGH: Platform trials could revolutionize neurological disease research by testing 4x more treatments simultaneously.… #Alzheimersdisease #Clinicalresearch #Neurologicaldisease #Parkinsonsdisease #Platformtrials
news.gmj.ge
May 31, 2026 at 6:20 PM
👏🏻 Nice to continue seeing the impact from the EU-PEARL project 2 years later!

@ihieurope.bsky.social #PPP #platformtrials #MDD #innovation
🎉 Excited to see the impact of EU-PEARL in advancing collaborative clinical research!
🙌 Shout-out to Stefan Gold & team at Charité for launching a platform trial to test depression treatments simultaneously🧠 Proud to be part of this @ihieurope.bsky.social -funded legacy! Learn more🔗 loom.ly/cSQYIsE
New depression trial will use EU-PEARL study designs
The first Europe-wide platform study on the safety and efficacy of treatments for depression will use study designs from the IMI EU-PEARL project.
loom.ly
February 1, 2025 at 8:17 AM
A recent article published in Contemporary Clinical Trial Communications evaluates the considerations raised during the regulatory & ethics review of five ID #PlatformTrials: #ECRAIDPrime, #RECLAIM, #REMAPCAP, #RECOVERY, and #SNAP.

Explore the full article here bit.ly/4v0qSCH

#TrialInnovation
Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases
Platform trials can address more than one clinical research question simultaneously and allow for the addition or removal of arms over time. The scien…
www.sciencedirect.com
March 31, 2026 at 9:30 AM
On Monday we discussed the topic of platform trials with the discussion anchored by the PROTECT-V trial

Touching upon #COVID #PlatformTrials and #Renalism

This was the #NephTrials initiative - a joint NephJC - ISN project

www.nephjc.com/news/protect-v
The PROTECT-V platform - RENALISM no more? — NephJC
This week on NephTrials we will discuss the PROTECT-V trial, a platform trial for preventing COVID-19 infections in the vulnerable kidney populations.
www.nephjc.com
March 13, 2024 at 11:21 PM